| Financial Year |
March 31 2023 |
| Monetary Funds |
247,880,594.88 |
| Held-for-trading Financial Assets |
511.92 |
| Notes Receivable |
5,951,505.00 |
| Accounts Receivable |
221,940,682.51 |
| Advances to Suppliers |
11,602,626.81 |
| Other Receivables |
16,639,231.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
404,283,063.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,939,177.50 |
| Total Current Assets |
921,920,680.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,352,480.24 |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,127,843.42 |
| Fixed Assetes |
251,646,901.13 |
| Under-construction Projects |
203,399.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,226,797.05 |
| R&D expenses |
-- |
| Goodwill |
45,766,991.54 |
| Long-Term Deferred and Prepaid Expenses |
12,083,199.88 |
| Deferred Income Tax Assets |
27,121,799.34 |
| Other Non-Current Assets |
14,968,380.13 |
| Sub-Total of Non-Current Assets |
465,503,643.53 |
| Total Assets |
1,387,424,324.39 |
| Short-Term Loans |
159,550,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
193,765,805.65 |
| Accounts Payable |
177,633,882.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,212,921.36 |
| Taxes Payable |
7,887,568.61 |
| Interest Payable |
128,027.78 |
| Dividend Payable |
-- |
| Other payables |
10,523,069.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,486,264.01 |
| Other Current Liabilities |
3,846,052.80 |
| Sub-Total of Current Liabilities |
645,556,227.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,315,202.67 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,069,849.39 |
| Total Liabilities |
694,626,076.48 |
| Paid-In Capital(Or Share Stock) |
349,510,030.00 |
| Capital Surplus |
648,496,411.93 |
| Surplus Reserve |
17,248,150.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-180,601,265.70 |
| Minority Stockholder's Interest |
22,216,821.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
670,581,426.22 |
| Owner's Equity（Stockholder's Equity） |
692,798,247.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,387,424,324.39 |
